Nu‑Med Plus Inc. Announces Asset Purchase, Issues Unregistered Shares

What Happened

• Nu‑Med Plus, Inc. (NASDAQ: NUMD) filed a Form 8‑K on August 25, 2026 reporting that it entered into a material definitive agreement and completed an asset purchase (the “Purchase”). The company also reported related unregistered sales of equity securities in connection with the transaction.
• The filing notes that the Purchase was an acquisition of assets and not the acquisition of a “business” as defined in Rule 11‑01(d) of Regulation S‑X; therefore, historical financial statements for the acquired properties are not required to be filed.

Key Details

• Filing date: August 25, 2026 (Form 8‑K, Accession No. 0001575872‑26‑000609).
• Items reported: 1.01 (Entry into a Material Definitive Agreement), 2.01 (Completion of Acquisition or Disposition of Assets), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits).
• The disclosures in the Explanatory Note and Items 1.01 and 2.01 are incorporated by reference into Item 3.02 of the filing.
• The company determined the Purchase is an asset acquisition (not a business), so historical financial statements of the acquired properties are not required under Regulation S‑X.

Why It Matters

• Investors should be aware Nu‑Med Plus completed a transaction that could affect the company’s assets and capital structure, including issuance of unregistered equity. These changes may influence dilution, financing, or operational scope.
• Because the filing treats the transaction as an asset purchase rather than a business acquisition, Nu‑Med Plus did not include historical financials for the acquired properties, which limits the amount of third‑party historical financial detail available to analyze the purchased assets.